AFC-HD AMS Life Science Co.,Ltd. [8254.T]
TOKYO, Apr 01 (Pulse News Wire) – Afc-hd AMS Life Science CO.,LTD. (8254.T) announced today that its subsidiary, Saisekya Co., Ltd., has formulated a three-year medium-term management plan aimed at achieving revenue of ¥291 million by the final fiscal year ending August 2029.
In recent years, Saisekya has achieved three consecutive profitable quarters since turning black in August 2023. The new plan focuses on enhancing profitability through initiatives such as attracting new tenants, expanding dining areas, and revitalizing operations in the Kawasaki region. Key strategies include the opening of Round One entertainment center in Yokosuka store during early summer 2026 and introducing a drugstore in Fujisawa store in summer 2026.
The plan also outlines goals to increase operating profit to ¥190 million, ordinary profit to ¥134 million, and net income to ¥8 million by the end of the fiscal year 2029. Additionally, efforts to improve capital structure and resume dividend payments are highlighted. Saisekya's progress towards these targets includes ongoing cost reduction measures and strategic tenant acquisitions designed to stabilize revenues and enhance customer traffic.
The company expects these steps to drive sustainable growth and strengthen its brand presence across key locations.
🟡 Confidence: Standard AI-translated content.